| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:34597818; PMID:35762964 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:28013214 |
| GO:0001568 | Blood vessel development | Increases phenotype | PMID:37021957 |
| GO:0003006 | Developmental process involved in reproduction | Affects phenotype | PMID:37788136 |
| GO:0004691 | Camp-dependent protein kinase activity | Increases phenotype | PMID:33711355 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:35762964 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:30802670; PMID:37788136 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:30802670 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30802670 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:34597818 |
| GO:0008219 | Cell death | Increases phenotype | PMID:33711355 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:34428494; PMID:36708983 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:30802670 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:33711355 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:33711355 |
| GO:0018108 | Peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:33711355 |
| GO:0030728 | Ovulation | Increases phenotype | PMID:33316053 |
| GO:0030850 | Prostate gland development | Decreases phenotype | PMID:30802670 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:33316053 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:37552060 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:28013214; PMID:30802670; PMID:31199487 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:28013214 |
| GO:0035941 | Androstenedione secretion | Decreases phenotype | PMID:28013214 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:28013214 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:34428494 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:34597818 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:33316053 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:33511402 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:36708983 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:36929940 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:24155963 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33711355 |
| GO:0048240 | Sperm capacitation | Increases phenotype | PMID:33711355 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:40323316 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:28013214 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:40323316 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31199487 |
| GO:0060305 | Regulation of cell diameter | Affects phenotype | PMID:37021957 |
| GO:0060376 | Positive regulation of mast cell differentiation | Increases phenotype | PMID:37021957 |
| GO:0060512 | Prostate gland morphogenesis | Decreases phenotype | PMID:31199487 |
| GO:0060618 | Nipple development | Affects phenotype | PMID:37788136 |
| GO:0061107 | Seminal vesicle development | Decreases phenotype | PMID:30802670 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:28655647; PMID:33983380; PMID:34597818 |
| GO:0061458 | Reproductive system development | Decreases phenotype | PMID:37788136 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:30802670 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30802670; PMID:33711355 |
| GO:0098739 | Import across plasma membrane | Increases phenotype | PMID:36708983 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:38954831 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:40323316 |
| GO:1903456 | Positive regulation of androst-4-ene-3,17-dione biosynthetic process | Decreases phenotype | PMID:28655647 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:37021957 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:30802670 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:37788136 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Increases phenotype | PMID:29734584 |
| GO:2000613 | Negative regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:29734584 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:37839492; PMID:39947446 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:37839492 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.